180 related articles for article (PubMed ID: 20128019)
1. MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
Smith CM; Watson DI; Michael MZ; Hussey DJ
World J Gastroenterol; 2010 Feb; 16(5):531-7. PubMed ID: 20128019
[TBL] [Abstract][Full Text] [Related]
2. Early events during neoplastic progression in Barrett's esophagus.
Reid BJ
Cancer Biomark; 2010; 9(1-6):307-24. PubMed ID: 22112482
[TBL] [Abstract][Full Text] [Related]
3. Barrett's esophagus in 2012: updates in pathogenesis, treatment, and surveillance.
Chandra S; Gorospe EC; Leggett CL; Wang KK
Curr Gastroenterol Rep; 2013 May; 15(5):322. PubMed ID: 23605564
[TBL] [Abstract][Full Text] [Related]
4. Cardiac mucosa indicates risk for Barrett esophagus.
Lenglinger J; Ringhofer C; Riegler FM
World J Gastroenterol; 2006 Aug; 12(32):5259. PubMed ID: 16937547
[No Abstract] [Full Text] [Related]
5. Author's reply: "Bile reflux is associated with Barrett's esophagus".
Iwaya Y
Dig Liver Dis; 2024 Jun; 56(6):1109. PubMed ID: 38614924
[No Abstract] [Full Text] [Related]
6. Global changes in gene expression of Barrett's esophagus compared to normal squamous esophagus and gastric cardia tissues.
Hyland PL; Hu N; Rotunno M; Su H; Wang C; Wang L; Pfeiffer RM; Gherman B; Giffen C; Dykes C; Dawsey SM; Abnet CC; Johnson KM; Acosta RD; Young PE; Cash BD; Taylor PR
PLoS One; 2014; 9(4):e93219. PubMed ID: 24714516
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Impact of Antireflux Treatment on Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus: Insights from a Mendelian Randomization Study.
Li Z; Yang K
Gastroenterology; 2024 May; 166(5):944-945. PubMed ID: 38246505
[No Abstract] [Full Text] [Related]
8. miRNA-221 and miRNA-483-3p Dysregulation in Esophageal Adenocarcinoma.
Bozzarelli I; Orsini A; Isidori F; Mastracci L; Malvi D; Lugaresi M; Fittipaldi S; Gozzellino L; Astolfi A; Räsänen J; D'Errico A; Rosati R; Fiocca R; Seri M; Krishnadath KK; Bonora E; Mattioli S
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339342
[TBL] [Abstract][Full Text] [Related]
9. Five-Class Classification of Cervical Pap Smear Images: A Study of CNN-Error-Correcting SVM Models.
Huong AKC; Tay KG; Ngu XTI
Healthc Inform Res; 2021 Oct; 27(4):298-306. PubMed ID: 34788910
[TBL] [Abstract][Full Text] [Related]
10. A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer.
Saller J; Jiang K; Xiong Y; Yoder SJ; Neill K; Pimiento JM; Pena L; Corbett FS; Magliocco A; Coppola D
Dig Dis Sci; 2022 Feb; 67(2):516-523. PubMed ID: 33713247
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential key genes in esophageal adenocarcinoma using bioinformatics.
Dong Z; Wang J; Zhang H; Zhan T; Chen Y; Xu S
Exp Ther Med; 2019 Nov; 18(5):3291-3298. PubMed ID: 31616504
[TBL] [Abstract][Full Text] [Related]
12. Framework for microRNA variant annotation and prioritization using human population and disease datasets.
Oak N; Ghosh R; Huang KL; Wheeler DA; Ding L; Plon SE
Hum Mutat; 2019 Jan; 40(1):73-89. PubMed ID: 30302893
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole Inhibits Cell Proliferation and Induces G0/G1 Cell Cycle Arrest through Up-regulating miR-203a-3p Expression in Barrett's Esophagus Cells.
Hou Y; Hu Q; Huang J; Xiong H
Front Pharmacol; 2017; 8():968. PubMed ID: 29375376
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
15. Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas.
Kong X; Gong S; Su L; Li C; Kong Y
J Cell Mol Med; 2018 Jan; 22(1):123-130. PubMed ID: 28799211
[TBL] [Abstract][Full Text] [Related]
16. From blood to breath: New horizons for esophageal cancer biomarkers.
Yazbeck R; Jaenisch SE; Watson DI
World J Gastroenterol; 2016 Dec; 22(46):10077-10083. PubMed ID: 28028355
[TBL] [Abstract][Full Text] [Related]
17. miR-203 is a predictive biomarker for colorectal cancer and its expression is associated with BIRC5.
Fu Q; Zhang J; Xu X; Qian F; Feng K; Ma J
Tumour Biol; 2016 Oct; ():. PubMed ID: 27714672
[TBL] [Abstract][Full Text] [Related]
18. Emerging therapeutic targets in esophageal adenocarcinoma.
Gaur P; Hunt CR; Pandita TK
Oncotarget; 2016 Jul; 7(30):48644-48655. PubMed ID: 27102294
[TBL] [Abstract][Full Text] [Related]
19. MiR-203 suppresses ZNF217 upregulation in colorectal cancer and its oncogenicity.
Li Z; Du L; Dong Z; Yang Y; Zhang X; Wang L; Li J; Zheng G; Qu A; Wang C
PLoS One; 2015; 10(1):e0116170. PubMed ID: 25621839
[TBL] [Abstract][Full Text] [Related]
20. Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status.
Zhai R; Wei Y; Su L; Liu G; Kulke MH; Wain JC; Christiani DC
Carcinogenesis; 2015 Jan; 36(1):87-93. PubMed ID: 25381453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
